Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Baricitinib effectively promotes hair regrowth and improves well-being in severe alopecia areata patients.

Topical tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Etanercept may cause lichen planopilaris, so doctors should be cautious.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Intensive immunosuppression can reduce relapse rates in multiple sclerosis patients, despite some side effects.

A new microneedle patch effectively treats atopic dermatitis by reducing skin stress and restoring immune balance.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Baricitinib was effective and safe for severe hair loss treatment over 6 months.

A new hair loss treatment using dissolving microneedles was found to speed up hair growth and was more effective than daily use of common hair growth drugs.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Baricitinib improved hair loss and arthritis in a lupus patient.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.

Blocking certain proteins on immune cells may help treat alopecia areata.

Baricitinib was more effective than a placebo in regrowing hair in adults with alopecia areata after 36 weeks.

Etanercept improved symptoms of a specific type of psoriatic arthritis in a patient who didn't respond to other treatments.

Methotrexate with steroids is slightly more effective than azathioprine with steroids for treating severe alopecia areata.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.